P/E ratio for Globus Medical (GMED)
P/E ratio as of April 2024 (TTM): 24.8
According to Globus Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.8235. At the end of 2022 the company had a P/E ratio of 39.3.
P/E ratio history for Globus Medical from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 39.3 | -19.45% |
| 2021 | 48.8 | -22.21% |
| 2020 | 62.7 | 68.28% |
| 2019 | 37.3 | 37.77% |
| 2018 | 27.0 | -26.29% |
| 2017 | 36.7 | 59.74% |
| 2016 | 23.0 | -2.56% |
| 2015 | 23.6 | -2.8% |
| 2014 | 24.3 | -11.06% |
| 2013 | 27.3 | 124.03% |
| 2012 | 12.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Stryker Corporation SYK | 49.3 | 98.46% | 🇺🇸 USA |
 Orthofix Medical
OFIX | -3.55 | -114.31% | 🇺🇸 USA |
 NuVasive NUVA | 73.6 | 196.54% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.